UK markets closed

Gerresheimer AG (GRRMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
75.100.00 (0.00%)
At close: 11:15AM EDT

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf 40468
49 211 61 81 00

IndustryMedical Instruments & Supplies
Full-time employees10,625

Key executives

NameTitlePayExercisedYear born
Mr. Dietmar SiemssenCEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board2MN/A1963
Dr. Bernd Metzner Ph.D.CFO & Member of the Management Board1.24MN/A1970
Dr. Lukas BurkhardtMember of the Management Board1.21MN/A1979
Ms. Katja SchnitzlerMember of Supervisory Board110.73kN/A1981
Ms. Carolin NadiloCorp. Director of Investor RelationsN/AN/AN/A
Ueli UtzingerGroup Sr. Director Marketing & CommunicationN/AN/AN/A
Mr. Helmut SchweigerMD & GM of Gerresheimer Horsovsky Tyn PlantN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Corporate governance

Gerresheimer AG’s ISS governance QualityScore as of 1 June 2022 is 3. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.